Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin-Therapy: A 6-Year Retrospective Study.
Georgia AnastasiouEvangelos N LiberopoulosErmioni PetkouAmalia Despoina KoutsogianniPetros Spyridwnas AdamidisGeorge LiamisEvangelia E NtzaniHaralampos MilionisPublished in: Diagnostics (Basel, Switzerland) (2023)
FLI is significantly and independently associated with new-onset T2D risk in patients initiating statin therapy.
Keyphrases
- end stage renal disease
- cardiovascular disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- type diabetes
- prognostic factors
- peritoneal dialysis
- coronary artery disease
- mesenchymal stem cells
- skeletal muscle
- adipose tissue
- metabolic syndrome
- insulin resistance
- smoking cessation
- cell therapy
- glycemic control